title: Meningeal carcinomatosis in HER2-overexpressing breast cancers.
authors.forename: F C
authors.initials: FC
authors.lastname: Bidard
authors.forename: M N
authors.initials: MN
authors.lastname: Guilhaume
authors.forename: H
authors.initials: H
authors.lastname: Gauthier
authors.forename: P H
authors.initials: PH
authors.lastname: Cottu
authors.forename: V
authors.initials: V
authors.lastname: Diéras
authors.forename: J Y
authors.initials: JY
authors.lastname: Pierga
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D018734:Genes, erbB-2; D006801:Humans; D008577:Meningeal Neoplasms / Q000473:pathology / Q000556:secondary*; D008875:Middle Aged; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab